TOI
Oncology Institute Inc
NASDAQ: TOI · HEALTHCARE · MEDICAL CARE FACILITIES
$4.02
+2.74% today
Updated 2026-06-05
Market cap
$523.91M
P/E ratio
—
P/S ratio
0.96x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$2 – $6
Volume
1.6M
Oncology Institute Inc (TOI) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.02
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$2.41
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.3B | $0.4B | $0.5B | $0.6B | $0.7B | $0.9B | $1.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -7.97%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.